Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology-a survey of Swiss clinicians.

Darphin, Xenia; Moor, Jeanne; da Silva, Cristina Espinosa; Richters, Anke; Özdemir, Berna C (2024). Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology-a survey of Swiss clinicians. Cancer reports, 7(2), e1961. Wiley 10.1002/cnr2.1961

[img]
Preview
Text
Cancer_Reports_-_2024_-_Darphin_-_Awareness_of_the_impact_of_sex_and_gender_in_the_disease_risk_and_outcomes_in_hematology.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

BACKGROUND

Although male and female cancer patients are distinct in many ways, there is a limited understanding in the differences between male and female biology and differing pharmacokinetic responses to cancer drugs. In fact, sex and gender are currently not considered in most treatment decisions in the fields of oncology and hematology. The lack of knowledge about potential sex differences in both disciplines may lead to differences in treatment efficacy, toxicity, and the overall survival (OS) of patients.

AIM

To evaluate their awareness about sex and gender in clinical practice we surveyed Swiss hematologists and oncologists from September to November 2022.

METHODS

We collected data about the clinical knowledge, experimental research, palliative care, quality of life, as well as the participant perception of the importance of sex and gender. We identified 767 eligible clinicians, of whom 150 completed the survey (20% response rate).

RESULTS

While most participants agreed that sex and gender were relevant when treating patients, it became clear that fewer participants knew about sex and gender differences in treatment toxicity and survival, which in turn would affect the treatment of their patients. Most participants agreed that this topic should be integrated into continuing education and research.

CONCLUSION

Our findings indicate the need for more awareness and training on sex and gender in cancer research and clinical care among oncologists and hematologists. Ideally, by better educating medical students and health professionals, a demand is created for improving research policies, publications and therefore patient care.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine

UniBE Contributor:

Moor, Jeanne Yvonne, Özdemir, Berna

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2573-8348

Publisher:

Wiley

Language:

English

Submitter:

Pubmed Import

Date Deposited:

23 Jan 2024 17:02

Last Modified:

29 Feb 2024 00:15

Publisher DOI:

10.1002/cnr2.1961

PubMed ID:

38258483

Uncontrolled Keywords:

cancer gender hematology oncology sex

BORIS DOI:

10.48350/192026

URI:

https://boris.unibe.ch/id/eprint/192026

Actions (login required)

Edit item Edit item
Provide Feedback